MedDataX Logo

Systane Clinical Experience Study

NCT ID: NCT00818909

Last Updated: 2012-02-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

941 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-01-31

Study Completion Date

2009-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To evaluate the physical effect of SYSTANE QID in people that have moderate to severe dry eyes and to establish doctor confidence to prescribe Systane.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Evaluation of Clinical Outcomes After the Use of SYSTANE® HYDRATION

NCT02470429

Dry Eye
COMPLETED NA

Study of Efficacy and Tolerability of SYSTANE Complete in Patients With Dry Eye Disease

NCT03492541

Dry Eye Disease
COMPLETED NA

Clinical Evaluation of Systane® Gel Drops in Dry Eye Subjects

NCT02380248

Dry Eye
COMPLETED NA

To Evaluate the Physical Effects of Systane(R) Lubricant Eye Drops Compared to Refresh Tears(R) Lubricant Eye Drops

NCT01160133

Dry Eye
COMPLETED NA

Evaluating Safety and Efficacy of FID 112903 Post Discontinuation of Long-term Use of RESTASIS® (Cyclosporine Ophthalmic Emulsion) 0.05%

NCT01198782

Dry Eye Syndrome
COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dry Eye Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Systane

Systane ocular product

Group Type EXPERIMENTAL

Systane

Intervention Type OTHER

Systane prescription

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Systane

Systane prescription

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* moderate to severe dry feeling eyes

Exclusion Criteria

* None
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Alcon Research

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CARES-3

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Clinical Evaluation Following Use of SYSTANE® ULTRA in the Management of Dry Eye
NCT02446015 COMPLETED NA
Evaluation of SYSTANE® BALANCE in Dry Eye Subjects With Lipid Deficiency
NCT01688726 COMPLETED NA
Systane Complete Multi-symptom Relief
NCT05056155 COMPLETED NA
Efficacy of Optive Versus Systane Concomitant With Restasis (Cyclosporine A) for the Treatment of Dry Eye Symptoms
NCT00399061 COMPLETED PHASE4
Evaluation of Blink Tears and Systane Concomitant With Restasis for the Treatment of Dry Eye Symptoms
NCT00565669 COMPLETED NA
SYSTANE® Family - Meibomian Deficiency
NCT01733745 COMPLETED NA
Efficacy and Safety of PRO-148 Ophthalmic Solution Versus SYSTANE® in the Treatment of Patients With Dry Eye Syndrome
NCT01541891 COMPLETED PHASE2
Autologous Serum Efficacy Study in Patients With Severe Dry Eye
NCT00779987 COMPLETED PHASE2
Safety/Efficacy of Systane Free vs Refresh Tears
NCT00348322 COMPLETED NA
Efficacy and Safety of a New Artificial Tear Formulation Compared With Systane Ultra Multidose in Participants With Dry Eye Disease
NCT04393441 COMPLETED PHASE3
Efficacy and Safety of PRO-148 Versus Systane®, in Patients With Mild to Moderate Dry Eye
NCT01657253 COMPLETED PHASE3
Evaluating Impact of Systane iLux on Dryness Symptoms and Wearing Time in Contact Lens Users
NCT05306561 RECRUITING NA
The Effect of SYSTANE® BALANCE on Tear Film Break Up Time in Dry Eye Subjects
NCT01718028 COMPLETED NA
Clinical Outcomes Following Treatment With Systane® Balance in Dry Eye Subjects
NCT01967147 COMPLETED NA
Efficacy of a New Nanoemulsion Artificial Tear Targeting Dry Eye Disease
NCT06188260 COMPLETED PHASE2
Comparative Study of Rohto Dry-Aid® and Systane® Ultra in Patients With Dry Eye
NCT03183089 COMPLETED PHASE4
Comparison of Tear Evaporation Rate With Systane Complete in Dry Eye and Non-Dry Eye
NCT04091581 COMPLETED PHASE4
A Late Phase II Study of KCT-0809 in Patients With Dry Eye Syndromes
NCT01890941 COMPLETED PHASE2
Clinical Study to Evaluate the Efficacy of Ectoin® Containing Eye Spray for Treatment of Dry Eye Disease
NCT03519815 COMPLETED NA
Evaluation of FID 114657 in Sjogren's Syndrome Subjects
NCT01079871 COMPLETED NA
A Study to Compare a New Eye Drop Formulation With Systane® Gel Drops and Genteal® Lubricant Gel Drops for Moderate to Severe Dry Eye Relief
NCT02455050 COMPLETED PHASE3
A Phase 4 Study Investigating the Efficacy of Retaine™ in Managing Signs and Symptoms Associated With Dry Eye Syndrome
NCT02139033 COMPLETED PHASE4
Study of SY-201 Ophthalmic Solution in Subjects With Dry Eye Disease
NCT05370495 COMPLETED PHASE1/PHASE2
A Phase III Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome
NCT02503189 COMPLETED PHASE3
Efficacy of FreshKote and Systane for the Treatment of Dry Eye and Improvement of Osmolarity
NCT01386073 UNKNOWN PHASE4